Literature DB >> 19684201

EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia.

Melissa A Cercone1, William Schroeder, Stacey Schomberg, Todd C Carpenter.   

Abstract

Ephrin family receptor tyrosine kinases are mediators of angiogenesis that may also regulate endothelial barrier function in the lung. Previous work has demonstrated that stimulation of EphA ephrin receptors causes increased vascular leak in the intact lung and increased permeability in cultured endothelial cells. Whether EphA receptors are involved in the permeability changes associated with lung injury is unknown. We studied this question in young rats exposed to viral respiratory infection combined with exposure to moderate hypoxia, a previously described lung injury model. We found that the EphA2 receptor is expressed in normal lung and that EphA2 expression is markedly upregulated in the lungs of hypoxic infected (HV) rats compared with normal control animals. Immunohistochemistry showed increased EphA2 expression principally in areas of edematous alveolar septae. In HV rats, EphA2 antagonism with either the soluble decoy receptor EphA2/Fc or with monoclonal anti-EphA2 antibody reduced albumin extravasation and histological evidence of edema formation (P<0.01). Vascular leak in HV rats is mediated in large part by increased lung endothelin (ET) levels. In HV rats, ET receptor antagonism with bosentan resulted in reduced EphA2 mRNA and protein expression (P<0.01). Experiments with cultured rat lung microvascular endothelial cells demonstrated that ET increases endothelial EphA2 expression. These results suggest that EphA2 expression is increased in lung injury, contributes to vascular leak in the injured lung, and is regulated in endothelial cells by ET. EphA2 may be a previously unrecognized contributor to the pathophysiology of lung injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19684201      PMCID: PMC2777500          DOI: 10.1152/ajplung.00118.2009

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  29 in total

1.  Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.

Authors:  Nikki Cheng; Dana M Brantley; Hua Liu; Qin Lin; Miriam Enriquez; Nick Gale; George Yancopoulos; Douglas Pat Cerretti; Thomas O Daniel; Jin Chen
Journal:  Mol Cancer Res       Date:  2002-11       Impact factor: 5.852

2.  Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion.

Authors:  A Pedram; M Razandi; R M Hu; E R Levin
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

3.  Microwave fixation of the lung.

Authors:  C R Turner; S Zuczek; D J Knudsen; E B Wheeldon
Journal:  Stain Technol       Date:  1990

4.  Viral respiratory infection increases susceptibility of young rats to hypoxia-induced pulmonary edema.

Authors:  T C Carpenter; J T Reeves; A G Durmowicz
Journal:  J Appl Physiol (1985)       Date:  1998-03

5.  Ephrin A receptors and ligands in lesions and normal-appearing white matter in multiple sclerosis.

Authors:  Raymond A Sobel
Journal:  Brain Pathol       Date:  2005-01       Impact factor: 6.508

6.  An enhancer element in the EphA2 (Eck) gene sufficient for rhombomere-specific expression is activated by HOXA1 and HOXB1 homeobox proteins.

Authors:  J Chen; H E Ruley
Journal:  J Biol Chem       Date:  1998-09-18       Impact factor: 5.157

7.  Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.

Authors:  Dana M Brantley; Nikki Cheng; Erin J Thompson; Qing Lin; Rolf A Brekken; Philip E Thorpe; Rebecca S Muraoka; Douglas Pat Cerretti; Ambra Pozzi; Dowdy Jackson; Charles Lin; Jin Chen
Journal:  Oncogene       Date:  2002-10-10       Impact factor: 9.867

8.  Endothelin B receptor deficiency predisposes to pulmonary edema formation via increased lung vascular endothelial cell growth factor expression.

Authors:  Todd Carpenter; Stacey Schomberg; Wolfgang Steudel; John Ozimek; Kelley Colvin; Kurt Stenmark; D Dunbar Ivy
Journal:  Circ Res       Date:  2003-08-14       Impact factor: 17.367

9.  EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.

Authors:  Dana M Brantley-Sieders; Justin Caughron; Donna Hicks; Ambra Pozzi; Joseph C Ruiz; Jin Chen
Journal:  J Cell Sci       Date:  2004-03-30       Impact factor: 5.285

10.  Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis.

Authors:  A Pandey; H Shao; R M Marks; P J Polverini; V M Dixit
Journal:  Science       Date:  1995-04-28       Impact factor: 47.728

View more
  20 in total

Review 1.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

2.  EphA2 stimulates VCAM-1 expression through calcium-dependent NFAT1 activity.

Authors:  Steven Daniel Funk; Alexandra C Finney; Arif Yurdagul; Christopher B Pattillo; A Wayne Orr
Journal:  Cell Signal       Date:  2018-05-21       Impact factor: 4.315

3.  MicroRNA dysregulation in lung injury: the role of the miR-26a/EphA2 axis in regulation of endothelial permeability.

Authors:  Ryan J Good; Laura Hernandez-Lagunas; Ayed Allawzi; Joanne K Maltzahn; Christine U Vohwinkel; Arun K Upadhyay; Uday B Kompella; Konstantin G Birukov; Todd C Carpenter; Carmen C Sucharov; Eva Nozik-Grayck
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-07-19       Impact factor: 5.464

Review 4.  Making Connections: Guidance Cues and Receptors at Nonneural Cell-Cell Junctions.

Authors:  Ian V Beamish; Lindsay Hinck; Timothy E Kennedy
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-11-01       Impact factor: 10.005

5.  Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.

Authors:  Manuel Nieto-Sampedro; Beatriz Valle-Argos; Diego Gómez-Nicola; Alfonso Fernández-Mayoralas; Manuel Nieto-Díaz
Journal:  Clin Med Insights Oncol       Date:  2011-09-21

6.  Eph-A2 promotes permeability and inflammatory responses to bleomycin-induced lung injury.

Authors:  Todd C Carpenter; William Schroeder; Kurt R Stenmark; Eric P Schmidt
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01       Impact factor: 6.914

7.  Targeted delivery of YSA-functionalized and non-functionalized polymeric nanoparticles to injured pulmonary vasculature.

Authors:  Madhoosudan A Patil; Arun K Upadhyay; Laura Hernandez-Lagunas; Ryan Good; Todd C Carpenter; Carmen C Sucharov; Eva Nozik-Grayck; Uday B Kompella
Journal:  Artif Cells Nanomed Biotechnol       Date:  2018-11-19       Impact factor: 5.678

8.  EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts.

Authors:  Elisa Giannoni; Maria Letizia Taddei; Matteo Parri; Francesca Bianchini; Michela Santosuosso; Renata Grifantini; Gabriella Fibbi; Benedetta Mazzanti; Lido Calorini; Paola Chiarugi
Journal:  J Mol Med (Berl)       Date:  2012-08-19       Impact factor: 4.599

Review 9.  Matrix metalloproteinases and protein tyrosine kinases: potential novel targets in acute lung injury and ARDS.

Authors:  Yael Aschner; Rachel L Zemans; Cory M Yamashita; Gregory P Downey
Journal:  Chest       Date:  2014-10       Impact factor: 9.410

10.  Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19.

Authors:  Rachelle Mendoza; Nayanendu Saha; Amir Momeni; Elmer Gabutan; Mouyed Alawad; Amir Dehghani; John Diks; Bo Lin; Donghai Wang; Mohamed Alshal; William Fyke; Bingcheng Wang; Juha P Himanen; Prem Premsrirut; Dimitar B Nikolov
Journal:  Heliyon       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.